ImmunoGen, Inc. (IMGN) Announces Conference Call to Discuss its Fourth Quarter and Fiscal Year 2013 Financial Results  
7/23/2013 10:39:15 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops anticancer therapeutics using its Targeted Antibody Payload (TAP) antibody-drug conjugate technology, today announced that the Company will host a conference call at 8:00 a.m. ET on Friday, August 2, 2013, to discuss ImmunoGen's financial results for the three-month period and fiscal year ended June 30, 2013. Management also will provide guidance for its fiscal year ending June 30, 2014 and an update on the Company.

Help employers find you! Check out all the jobs and post your resume.